TNFRSF9 and neoplasm: 4-1BB (CD137) is another co-stimulatory molecule that has been targeted by antibodies for its role in the survival and expansion of activated T cells.40, 41 It has been shown that the systemic administration of agonistic anti-4-1BB antibodies enhances tumor immunity and tumor rejection in mice.33